Regulation of FOXO1 by TAK1-Nemo-like Kinase Pathway
Cell Nucleus
Transcriptional Activation
570
0303 health sciences
Forkhead Box Protein O1
Intracellular Signaling Peptides and Proteins
Forkhead Transcription Factors
Protein Serine-Threonine Kinases
Kidney
MAP Kinase Kinase Kinases
Phosphatidylinositol 3-Kinases
03 medical and health sciences
COS Cells
Chlorocebus aethiops
Animals
Humans
Drosophila
RNA, Messenger
Phosphorylation
Luciferases
Protein Processing, Post-Translational
Proto-Oncogene Proteins c-akt
Signal Transduction
DOI:
10.1074/jbc.m110.101824
Publication Date:
2010-01-09T02:06:43Z
AUTHORS (4)
ABSTRACT
The FOXO family of forkhead transcription factors has a variety of important functions in stress response, metabolism, cell cycle, apoptosis, longevity, etc. The transcriptional activity and subcellular localization of FOXO are tightly regulated by post-translational modifications, including phosphorylation by various kinases. Here, we report that the transforming growth factor-beta-activated kinase (TAK1)-Nemo-like kinase (NLK) pathway negatively regulates FOXO1. We show that NLK binds and phosphorylates FOXO1 at Pro-directed Ser/Thr residues in the transactivation domain. The phosphorylation by TAK1-NLK pathway inhibits the transcriptional activity of FOXO1 and excludes FOXO1 from the nucleus, which is independent of phosphatidylinositol 3-kinase/Akt pathway. Consistently, knockdown of TAK1-NLK pathway dephosphorylates FOXO1 and decreases phospho-Ser-329 FOXO1 level. It also induces translocation of FOXO1 into the nucleus and leads to an increase in mRNA levels of FOXO target genes and poly(ADP-ribose) polymerase cleavage. In addition, we show the interaction between NLK and FOXO1 is evolutionarily conserved in Drosophila. Collectively, these findings provide the first evidence that TAK1-NLK pathway is a novel regulator of FOXO1.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (41)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....